Tubulis has dosed the first subject in the multicentre Phase I/IIa 5-STAR 1-01 trial to clinically evaluate its second drug ...

Scientists from Nanjing University recently developed a new solid-phase microextraction (SPME)-based system for detecting ...

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Faced with a solid economy and mounting inflation concerns, the U.S. central bank has said it will “move cautiously” on ...

Hudson Technologies is witnessing headwinds related to lower refrigerant prices, which should be short-lived. Read why I have ...

"If we get City, it'll be difficult for both sides, but we'll have to wait for the draw," added the Real Madrid coach.

I was fascinated by the idea of jet packs when I was a kid. They were sci-fi magic, and the idea that you could strap into an ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial ...

About 83% of the low-carbon hydrogen capacity coming online by 2030 is expected to come from green hydrogen plants, while the ...